Loading clinical trials...
Loading clinical trials...
BF2.649 in Patients With Obstructive Sleep Apnea Syndrome (OSA) and Treated by Nasal Continuous Positive Airway Pressure (nCPAP), But Still Complaining of Excessive Daytime Sleepiness (EDS)
Conditions
Interventions
BF2.649
Placebo
Locations
1
France
CHU Grenoble
Grenoble, France
Start Date
August 1, 2011
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
January 21, 2015
NCT06430957
NCT07292922
NCT07225686
NCT03307330
NCT07380321
NCT07345312
Lead Sponsor
Bioprojet
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions